Technical And Vocational Education Market Size, Share & Trends Analysis Report By Course (STEM, Non-STEM), By Learning Mode (Online, Offline), By Organization, By End Use, And Segment Forecasts, 2025 - 2030

Technical And Vocational Education Market Size, Share & Trends Analysis Report By Course (STEM, Non-STEM), By Learning Mode (Online, Offline), By Organization, By End Use, And Segment Forecasts, 2025 - 2030


Technical And Vocational Education Market Growth & Trends

The global technical and vocational education market size is expected to reach USD 1,432.94 billion by 2030, registering a CAGR of 10.0% from 2025 to 2030, according to a new report by Grand View Research, Inc. The increasing use of technology in education and the rising demand for job-relevant skills in various sectors are expected to propel industry growth. Technical and vocational education provides support services for the educational sectors that are both instructional and non-instructional. The widespread use of the internet has demonstrated that e-education continues to proliferate and has a lot of untapped potential that could alter the industry’s performance.

The COVID-19 pandemic had a negative impact on the industry in 2020. Education providers gradually shifted to online learning and blended (online and offline) learning and training mode, which became a more efficient way of education. Advanced technology and AI-based education have played a crucial role, especially during the COVID-19 pandemic in offering services to a larger set of people due to increased accessibility worldwide. As a result, there has been a significant increase in demand for technical & vocational education during the pandemic. The STEM course type segment led the industry in 2021due to the easy availability of STEM courses.

In addition, STEM courses provide skills related to technology, engineering, science, and mathematics, which result in better job opportunities. Key players are adopting strategies, such as service launches, several developments, and technological innovations. For instance, in May 2020, SAP and UNICEF partnered to develop a training program in vocational education for the young population in the world to prepare them for job-relevant skills with quality education. The partnership aimed to provide programs to the disadvantaged youth of the world and provide them with decent jobs from acquired skills.

Technical And Vocational Education Market Report Highlights
  • The academic institutions & individual end-user segments dominated the industry in 2024. Pursuing these courses during academic education by students and individuals gives them an added advantage in procuring better job opportunities and salaries
  • Europe accounted for the largest share in 2024. European technical and vocational systems are supported by a strong network of collaborators in the field of vocational education
  • Social partners, including businesses and labor unions, are involved in the governance of these networks through a variety of chambers, committees, and councils
  • Asia Pacific is expected to register the fastest CAGR over the forecast period owing to the rapid economic development as a result of the rising focus on bridging the skilled labor supply and demand gap
  • Various initiatives have been started to support vocational and technical education, enhance disposable income, and expand industry potential for companies in the region
  • For instance, in India, the Ministry of Skill Development and Entrepreneurship has come up with various schemes and initiatives to boost the skills that are mutually recognized and have importance in the future skillset required for work
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. U.S. Clinical Trials Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Regulatory Landscape
3.4. Technological Landscape
3.5. Pricing Model Analysis
3.6. Clinical Trial Volume Analysis, 2024
3.7. U.S. Clinical Trials Market Analysis Tools
3.7.1. Porter’s Five Forces Analysis
3.7.2. PESTEL Analysis
3.7.3. COVID-19 Impact Analysis
3.8. Product Pipeline Analysis by Stage
3.8.1. Therapeutics in Development
3.8.2. Vaccines in Development
Chapter 4. U.S. Clinical Trials Market: Phase Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Clinical Trials Market: Phase Movement Analysis & Market Share, 2024 & 2030
4.3. Phase I
4.3.1. Phase I Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Phase II
4.4.1. Phase II Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Phase III
4.5.1. Phase III Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Phase IV
4.6.1. Phase IV Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. U.S. Clinical Trials Market: Study Design Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Clinical Trials Market: Study Design Movement Analysis & Market Share, 2024 & 2030
5.3. Interventional
5.3.1. Interventional Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Observational
5.4.1. Observational Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Expanded Access
5.5.1. Expanded Access Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. U.S. Clinical Trials Market: Indication Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Clinical Trials Market: Indication Movement Analysis & Market Share, 2024 & 2030
6.3. Autoimmune/Inflammation
6.3.1. Autoimmune/Inflammation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.2. Rheumatoid Arthritis
6.3.2.1. Rheumatoid Arthritis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.3. Multiple Sclerosis
6.3.3.1. Multiple Sclerosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.4. Osteoarthritis
6.3.4.1. Osteoarthritis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.5. Irritable Bowel Syndrome (IBS)
6.3.5.1. Irritable Bowel Syndrome (IBS) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.6. Others
6.3.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Pain Management
6.4.1. Pain Management Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.2. Chronic Pain
6.4.2.1. Chronic Pain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.3. Acute Pain
6.4.3.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Oncology
6.5.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.2. Blood Cancer
6.5.2.1. Blood Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.3. Solid Tumors
6.5.3.1. Solid Tumors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.4. Others
6.5.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. CNS Conditions
6.6.1. CNS Conditions Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.2. Epilepsy
6.6.2.1. Epilepsy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.3. Parkinson's Disease (PD)
6.6.3.1. Parkinson's Disease (PD) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.4. Huntington's Disease
6.6.4.1. Huntington's Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.5. Stroke
6.6.5.1. Stroke Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.6. Traumatic Brain Injury (TBI)
6.6.6.1. Traumatic Brain Injury (TBI) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.7. Amyotrophic Lateral Sclerosis (ALS)
6.6.7.1. Amyotrophic Lateral Sclerosis (ALS) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.8. Muscle Regeneration
6.6.8.1. Muscle Regeneration Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.9. Others
6.6.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Diabetes
6.7.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. Obesity
6.8.1. Obesity Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.9. Cardiovascular
6.9.1. Cardiovascular Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.10. Others
6.10.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. U.S. Clinical Trials Market: Indication by Study Design Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Clinical Trials Market: Indication Movement Analysis & Market Share, 2024 & 2030
7.3. Autoimmune/Inflammation
7.3.1. Autoimmune/Inflammation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.2. Interventional
7.3.2.1. Interventional Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.3. Observational
7.3.3.1. Observational Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.4. Expanded Access
7.3.4.1. Expanded Access Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Pain Management
7.4.1. Pain Management Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.2. Interventional
7.4.2.1. Interventional Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.3. Observational
7.4.3.1. Observational Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.4. Expanded Access
7.4.4.1. Expanded Access Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Oncology
7.5.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. Interventional
7.5.2.1. Interventional Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Observational
7.5.3.1. Observational Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.4. Expanded Access
7.5.4.1. Expanded Access Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. CNS Conditions
7.6.1. CNS Conditions Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2. Interventional
7.6.2.1. Interventional Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3. Observational
7.6.3.1. Observational Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4. Expanded Access
7.6.4.1. Expanded Access Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Diabetes
7.7.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.2. Interventional
7.7.2.1. Interventional Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.3. Observational
7.7.3.1. Observational Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.4. Expanded Access
7.7.4.1. Expanded Access Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8. Obesity
7.8.1. Obesity Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.2. Interventional
7.8.2.1. Interventional Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.3. Observational
7.8.3.1. Observational Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.4. Expanded Access
7.8.4.1. Expanded Access Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.9. Cardiovascular
7.9.1. Cardiovascular Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.9.2. Interventional
7.9.2.1. Interventional Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.9.3. Observational
7.9.3.1. Observational Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.9.4. Expanded Access
7.9.4.1. Expanded Access Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.10. Others
7.10.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.10.2. Interventional
7.10.2.1. Interventional Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.10.3. Observational
7.10.3.1. Observational Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.10.4. Expanded Access
7.10.4.1. Expanded Access Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. U.S. Clinical Trials Market: Service Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. Clinical Trials Market: Sponsor Movement Analysis & Market Share, 2024 & 2030
8.3. Protocol Designing
8.3.1. Protocol Designing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4. Site Identification
8.4.1. Site Identification Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. Patient Recruitment
8.5.1. Patient Recruitment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Laboratory Services
8.6.1. Laboratory Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.7. Bioanalytical Testing Services
8.7.1. Bioanalytical Testing Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.8. Clinical Trial Data Management Services
8.8.1. Clinical Trial Data Management Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.9. Others
8.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. U.S. Clinical Trials Market: Sponsor Estimates & Trend Analysis
9.1. Segment Dashboard
9.2. Clinical Trials Market: Sponsor Movement Analysis & Market Share, 2024 & 2030
9.3. Pharmaceutical & Biopharmaceutical Companies
9.3.1. Pharmaceutical & Biopharmaceutical Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4. Medical Device Companies
9.4.1. Medical Device Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 10. Competitive Landscape
10.1. Market Participant Categorization
10.1.1. Market Leaders
10.1.2. Emerging Players
10.2. Market Position Analysis, 2024
10.3. Key Company Profiles
10.3.1. IQVIA
10.3.1.1. Company Overview
10.3.1.2. Financial Performance
10.3.1.3. Service Benchmarking
10.3.1.4. Strategic Initiatives
10.3.2. Fortrea Inc.
10.3.2.1. Company Overview
10.3.2.2. Financial Performance
10.3.2.3. Service Benchmarking
10.3.2.4. Strategic Initiatives
10.3.3. PAREXEL International Corporation
10.3.3.1. Company Overview
10.3.3.2. Financial Performance
10.3.3.3. Service Benchmarking
10.3.3.4. Strategic Initiatives
10.3.4. Thermo Fisher Scientific Inc.
10.3.4.1. Company Overview
10.3.4.2. Financial Performance
10.3.4.3. Service Benchmarking
10.3.4.4. Strategic Initiatives
10.3.5. Charles River Laboratories
10.3.5.1. Company Overview
10.3.5.2. Financial Performance
10.3.5.3. Service Benchmarking
10.3.5.4. Strategic Initiatives
10.3.6. ICON Plc
10.3.6.1. Company Overview
10.3.6.2. Financial Performance
10.3.6.3. Service Benchmarking
10.3.6.4. Strategic Initiatives
10.3.7. Wuxi AppTec Inc.
10.3.7.1. Company Overview
10.3.7.2. Financial Performance
10.3.7.3. Service Benchmarking
10.3.7.4. Strategic Initiatives
10.3.8. Medpace
10.3.8.1. Company Overview
10.3.8.2. Financial Performance
10.3.8.3. Service Benchmarking
10.3.8.4. Strategic Initiatives
10.3.9. Syneos Health
10.3.9.1. Company Overview
10.3.9.2. Financial Performance
10.3.9.3. Service Benchmarking
10.3.9.4. Strategic Initiatives
10.3.10. AstraZeneca
10.3.10.1. Company Overview
10.3.10.2. Financial Performance
10.3.10.3. Service Benchmarking
10.3.10.4. Strategic Initiatives
10.3.11. Merck & Co.
10.3.11.1. Company Overview
10.3.11.2. Financial Performance
10.3.11.3. Service Benchmarking
10.3.11.4. Strategic Initiatives
10.3.12. Eli Lilly and Company
10.3.12.1. Company Overview
10.3.12.2. Financial Performance
10.3.12.3. Service Benchmarking
10.3.12.4. Strategic Initiatives
10.3.13. Novo Nordisk A/S
10.3.13.1. Company Overview
10.3.13.2. Financial Performance
10.3.13.3. Service Benchmarking
10.3.13.4. Strategic Initiatives
10.3.14. Pfizer
10.3.14.1. Company Overview
10.3.14.2. Financial Performance
10.3.14.3. Service Benchmarking
10.3.14.4. Strategic Initiatives
10.3.15. Caidya
10.3.15.1. Company Overview
10.3.15.2. Financial Performance
10.3.15.3. Service Benchmarking
10.3.15.4. Strategic Initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings